Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia

被引:37
|
作者
Shen, Yi [1 ]
Ding, Yuanjie [1 ]
Ma, Qing [2 ,3 ]
Zhao, Lei [4 ]
Guo, Xudong [1 ]
Shao, Yi [1 ]
Niu, Chen [1 ]
He, Yan [1 ]
Zhang, Feng [1 ]
Zheng, Deqiang [1 ]
Wei, Wenqiang [2 ,3 ]
Liu, Fen [1 ]
机构
[1] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Beijing 100021, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Univ Iowa, Carver Coll Med, Holden Comprehens Canc Ctr, Dept Mol Physiol & Biophys, Iowa City, IA USA
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
MICRORNA EXPRESSION PROFILE; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; CANCER; SERUM; SIGNATURES; PANEL; PROGRESSION; PROGNOSIS; MIR-92A;
D O I
10.1158/1055-9965.EPI-18-1199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating miRNAs have been identified as diagnostic biomarkers for esophageal squamous cell carcinoma (ESCC), but their efficacy in discovering early-stage ESCC is still unsatisfying. Esophageal squamous dysplasia (ESD) is the precursor lesion of ESCC. Notably, little is known about the role(s) of circulating miRNAs in identifying ESD. In this study, we, therefore, aimed to identify serum miRNAs as novel diagnostic markers for detecting ESD and ESCC. Methods: The genome-wide miRNA expression was profiled in 104 (52 ESCC and 52 controls) serum samples using microarray. Seven candidate miRNAs from the microarray assay were evaluated for their diagnostic performance in another cohort of 266 participants (96 ESCC, 92 ESD, and 78 healthy controls). Results: The serum levels of miR-16-5p, miR-197-5p, miR-451a, and miR-92a-3p were associated with ESCC; the biomarker based on the panel of these four miRNAs could efficiently distinguish patients with ESCC from the controls [AUC = 0.856; 95% confidence interval (CI), 0.794-0.905; P < 0.001]. The serum levels of miR-16-5p, miR-320c, miR-638, and miR-92a-3p were significantly higher in patients with ESD than in controls, and this four-miRNA signature could efficiently differentiate patients with ESD from the controls (AUC = 0.842; 95% CI, 0.778-0.893; P < 0.001). In addition, compared with serum carcinoembryonic antigen and carbohydrate antigen 199, miRNA-based panels had a better diagnostic performance in distinguishing patients with ESCC and ESD from healthy controls. Conclusions: Our study identified two novel panels of circulating miRNAs with high efficiency in detecting ESCC and ESD, suggesting that circulating miRNAs, in particular the combination of them, might serve as noninvasive biomarkers for the early detection of ESCC. Impact: This study suggests the feasibility of using circular miRNA-based blood tests to aid in the detection of ESD and ESCC.
引用
收藏
页码:1212 / 1220
页数:9
相关论文
共 50 条
  • [21] Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging
    Xu, Jing
    Chen, Yanhua
    Zhang, Ruiping
    He, Jiuming
    Song, Yongmei
    Wang, Jingbo
    Wang, Huiqing
    Wang, Luhua
    Zhan, Qimin
    Abliz, Zeper
    SCIENTIFIC REPORTS, 2016, 6
  • [22] Identification of Serum MicroRNAs as Novel Biomarkers in Esophageal Squamous Cell Carcinoma Using Feature Selection Algorithms
    Zheng, Deqiang
    Ding, Yuanjie
    Ma, Qing
    Zhao, Lei
    Guo, Xudong
    Shen, Yi
    He, Yan
    Wei, Wenqiang
    Liu, Fen
    FRONTIERS IN ONCOLOGY, 2019, 8
  • [23] Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics
    Li, Cheng-Yun
    Zhang, Wen-Wen
    Xiang, Ji-Lian
    Wang, Xing-Hua
    Li, Jin
    Wang, Jun-Ling
    CHINESE MEDICAL JOURNAL, 2019, 132 (18) : 2213 - 2222
  • [24] Discovery and validation of combined biomarkers for the diagnosis of esophageal intraepithelial neoplasia and esophageal squamous cell carcinoma
    Zheng, Ya-Qi
    Huang, Hai-Hua
    Chen, Shu-Xian
    Xu, Xiu-E
    Li, Zhi-Mao
    Li, Yue-Hong
    Chen, Su-Zuan
    Luo, Wen-Xiong
    Guo, Yi
    Liu, Wei
    Li, En-Min
    Xu, Li-Yan
    JOURNAL OF PROTEOMICS, 2024, 304
  • [25] Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma
    Takikita, Mikiko
    Hu, Nan
    Shou, Jian-zhong
    Wang, Quan-Hong
    Giffen, Carol
    Taylor, Philip R.
    Hewitt, Stephen M.
    BMC CANCER, 2009, 9 : 310
  • [26] Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma
    Wang, Wenjian
    He, Xiaotian
    Zheng, Zehua
    Ma, Xiaofan
    Hu, Xueting
    Wu, Duoguang
    Wang, Minghui
    MOLECULAR CANCER, 2017, 16
  • [27] Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma
    Hou, Bo
    Ishinaga, Hajime
    Midorikawa, Kaoru
    Shah, Said Ahmad
    Nakamura, Satoshi
    Hiraku, Yusuke
    Oikawa, Shinji
    Murata, Mariko
    Takeuchi, Kazuhiko
    CANCER BIOLOGY & THERAPY, 2015, 16 (07) : 1042 - 1046
  • [28] Rule discovery and distance separation to detect reliable miRNA biomarkers for the diagnosis of lung squamous cell carcinoma
    Song, Renhua
    Liu, Qian
    Hutvagner, Gyorgy
    Hung Nguyen
    Ramamohanarao, Kotagiri
    Wong, Limsoon
    Li, Jinyan
    BMC GENOMICS, 2014, 15
  • [29] Novel Candidate Biomarkers of Chemoradiosensitivity in Esophageal Squamous Cell Carcinoma: A Systematic Review
    Sato, Yusuke
    Motoyama, Satoru
    Saito, Hajime
    Minamiya, Yoshihiro
    EUROPEAN SURGICAL RESEARCH, 2016, 56 (3-4) : 141 - 153
  • [30] Identification and validation of potential novel biomarkers for oral squamous cell carcinoma
    Zhang, Mengxue
    Chen, Xiao
    Chen, He
    Zhou, Minyue
    Liu, Yaoqiang
    Hou, Yali
    Nie, Minhai
    Liu, Xuqian
    BIOENGINEERED, 2021, 12 (01) : 8845 - 8862